ProShares Ultra Nasdaq Biotechnology
NASDAQ: BIB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Financial Services
- Industry
- Asset Management
- Headquarters
- Bethesda, United States
- IPO year
- 2010
- Market cap
- $80.3M
- Website
- https://www.proshares.com/funds/bib.html
Loading BIB…
Loading profile data…Frequently asked questions about BIB
What does ProShares Ultra Nasdaq Biotechnology (BIB) do?
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development a...
Where does BIB trade?
ProShares Ultra Nasdaq Biotechnology (BIB) trades on the NASDAQ.
What sector is BIB in?
ProShares Ultra Nasdaq Biotechnology (BIB) operates in the Financial Services sector, specifically in the Asset Management industry.
Where is ProShares Ultra Nasdaq Biotechnology headquartered?
ProShares Ultra Nasdaq Biotechnology is headquartered in United States.
Does BIB pay a dividend?
Yes — ProShares Ultra Nasdaq Biotechnology (BIB) paid a trailing twelve-month dividend of USD 0.49 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIB go public?
ProShares Ultra Nasdaq Biotechnology (BIB) completed its initial public offering in 2010.